- Home
- TECH vs CELH Comparison
TECH vs CELH Comparison
Compare TECH & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CELH
- Stock Information
- Founded
- TECH 1976
- CELH 2004
- Country
- TECH United States
- CELH United States
- Employees
- TECH N/A
- CELH N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CELH Beverages (Production/Distribution)
- Sector
- TECH Health Care
- CELH Consumer Staples
- Exchange
- TECH Nasdaq
- CELH Nasdaq
- Market Cap
- TECH 7.9B
- CELH 7.5B
- IPO Year
- TECH 1989
- CELH N/A
- Fundamental
- Price
- TECH $47.86
- CELH $38.94
- Analyst Decision
- TECH Buy
- CELH Buy
- Analyst Count
- TECH 10
- CELH 17
- Target Price
- TECH $73.44
- CELH $47.41
- AVG Volume (30 Days)
- TECH 2.3M
- CELH 7.0M
- Earning Date
- TECH 05-07-2025
- CELH 05-06-2025
- Dividend Yield
- TECH 0.67%
- CELH N/A
- EPS Growth
- TECH N/A
- CELH N/A
- EPS
- TECH 0.83
- CELH 0.32
- Revenue
- TECH $1,208,770,000.00
- CELH $1,329,198,000.00
- Revenue This Year
- TECH $8.19
- CELH $57.42
- Revenue Next Year
- TECH $8.61
- CELH $21.56
- P/E Ratio
- TECH $57.61
- CELH $119.85
- Revenue Growth
- TECH 4.72
- CELH N/A
- 52 Week Low
- TECH $46.44
- CELH $21.10
- 52 Week High
- TECH $85.57
- CELH $98.85
- Technical
- Relative Strength Index (RSI)
- TECH 41.02
- CELH 65.75
- Support Level
- TECH $46.77
- CELH $32.36
- Resistance Level
- TECH $54.40
- CELH $36.16
- Average True Range (ATR)
- TECH 2.12
- CELH 1.73
- MACD
- TECH 0.45
- CELH 0.14
- Stochastic Oscillator
- TECH 14.29
- CELH 86.81
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.